Vaccine volatility – what have investors done?

Today was a monumental day on the markets. Pfizer announced that its Covid-19 vaccine has been found to be 90% effective, comfortably the most important scientific breakthrough thus far in the fight against the virus. Now, your immediate reaction might be to buy Pfizer shares. Funnily enough, at time of writing, Pfizer was only up 6% after the news. That …

View Post

Dis-Chem’s regulatory headaches may hurt its M&A strategy

Dis-Chem had a rough few months in the court of public opinion. The company wanted special concessions from landlords, even though it was one of the few retailers allowed to remain open. That paled in comparison to the reputational damage from the allegations of hiking the prices of masks. Thankfully for Dis-Chem, Clicks had a real “hold my beer” moment …

View Post

Car market fires on all cylinders in Q3

One of the themes in the latest raft of corporate earnings is that the automotive sector’s engine is starting to rev again. The driver of the recovery is China, with the horrors of lockdown seemingly long forgotten. Western nations are dealing with renewed pandemic issues, as countries like the UK get locked down again. The purchase of a new car …

View Post

Car market fires on all cylinders in Q3

One of the themes in the latest raft of corporate earnings is that the automotive sector’s engine is starting to rev again. The driver of the recovery is China, with the horrors of lockdown seemingly long forgotten. Western nations are dealing with renewed pandemic issues, as countries like the UK get locked down again. The purchase of a new car …

View Post

Car market fires on all cylinders in Q3

One of the themes in the latest raft of corporate earnings is that the automotive sector’s engine is starting to rev again. The driver of the recovery is China, with the horrors of lockdown seemingly long forgotten. Western nations are dealing with renewed pandemic issues, as countries like the UK get locked down again. The purchase of a new car …

View Post

Aspen gives South Africa a booster shot

Despite the negative cloud that we typically find ourselves under in South Africa, we still boast world-class technology and manufacturing capabilities in a number of industries. Aspen Pharmacare has had a really tough few years on the JSE, having struggled with a debt-funded globalisation strategy that hasn’t worked out. However, the market cheered the news that Aspen has entered into …

View Post